WAVE Life Sciences Ltd (WVE)
15.00
-0.69
(-4.40%)
USD |
NASDAQ |
Nov 14, 16:00
15.01
+0.01
(+0.07%)
After-Hours: 18:11
WAVE Life Sciences Enterprise Value: 1.803B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.803B |
| November 12, 2024 | 1.828B |
| November 11, 2024 | 1.897B |
| November 08, 2024 | 1.897B |
| November 07, 2024 | 1.696B |
| November 06, 2024 | 1.617B |
| November 05, 2024 | 1.572B |
| November 04, 2024 | 1.566B |
| November 01, 2024 | 1.571B |
| October 31, 2024 | 1.556B |
| October 30, 2024 | 1.632B |
| October 29, 2024 | 1.692B |
| October 28, 2024 | 1.716B |
| October 25, 2024 | 1.649B |
| October 24, 2024 | 1.695B |
| October 23, 2024 | 1.676B |
| October 22, 2024 | 1.696B |
| October 21, 2024 | 1.731B |
| October 18, 2024 | 1.756B |
| October 17, 2024 | 1.668B |
| October 16, 2024 | 1.705B |
| October 15, 2024 | 913.80M |
| October 14, 2024 | 935.00M |
| October 11, 2024 | 920.04M |
| October 10, 2024 | 876.38M |
| Date | Value |
|---|---|
| October 09, 2024 | 895.09M |
| October 08, 2024 | 843.95M |
| October 07, 2024 | 848.93M |
| October 04, 2024 | 895.09M |
| October 03, 2024 | 906.31M |
| October 02, 2024 | 947.48M |
| October 01, 2024 | 881.37M |
| September 30, 2024 | 868.89M |
| September 27, 2024 | 880.12M |
| September 26, 2024 | 846.44M |
| September 25, 2024 | 969.93M |
| September 24, 2024 | 867.65M |
| September 23, 2024 | 512.14M |
| September 20, 2024 | 554.55M |
| September 19, 2024 | 586.99M |
| September 18, 2024 | 528.36M |
| September 17, 2024 | 558.30M |
| September 16, 2024 | 591.97M |
| September 13, 2024 | 577.01M |
| September 12, 2024 | 577.01M |
| September 11, 2024 | 582.00M |
| September 10, 2024 | 589.48M |
| September 09, 2024 | 591.97M |
| September 06, 2024 | 485.95M |
| September 05, 2024 | 498.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-36.38M
Minimum
May 13 2022
1.897B
Maximum
Nov 08 2024
291.16M
Average
231.82M
Median
May 11 2020
Enterprise Value Benchmarks
| Raffles Medical Group Ltd | 1.078B |
| Haw Par Corp Ltd | -539.71M |
| EUDA Health Holdings Ltd | 160.01M |
| CytoMed Therapeutics Ltd | 21.16M |
| Mobile-health Network Solutions | 5.868M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.92M |
| Revenue (Quarterly) | 19.69M |
| Total Expenses (Quarterly) | 54.69M |
| EPS Diluted (Quarterly) | -0.25 |
| Profit Margin (Quarterly) | -167.2% |
| Earnings Yield | -3.80% |
| Normalized Earnings Yield | -4.251 |